Chikungunya outbreak in Nicaragua: a fresh travel warning and what it means
What happened
On 3 September 2026, the US Centers for Disease Control and Prevention updated its travel health notice for chikungunya in Nicaragua, keeping it at Level 2, which means travellers should practise enhanced precautions. Chikungunya is a virus spread by mosquito bites. The name comes from a word in the Kimakonde language meaning roughly "to become contorted", which describes the stooped posture of people with the severe joint pain it causes. Nicaragua is reporting a rise in cases, with most of them in the capital, Managua. The CDC notes more than 400 cases reported across the country since May 2026. Independent local reporting has suggested higher numbers than have been officially confirmed, with one account describing 1,384 cases between 23 May and 8 August 2026, more than half of them in the final fortnight of that period. Whichever figure is closer to the truth, the direction is the same. This is Nicaragua's first chikungunya outbreak since 2021. The CDC's advice is to protect yourself by preventing mosquito bites. It also says vaccination is recommended for travellers going to an area with a chikungunya outbreak, and that people who are pregnant, particularly those close to giving birth, should reconsider travel to affected areas.
Why this matters
Nicaragua is not a mass-market British holiday destination, but plenty of people go. Backpackers on the Central America route, volunteers, people visiting family, and travellers combining it with Costa Rica, which has had its own chikungunya notice this year. The reason chikungunya deserves attention is not that it usually kills people. It usually does not. The reason is what it can leave behind. Most people get a sudden high fever and severe joint pain, often in the hands, wrists, ankles and feet. Many also get a rash, headache and muscle pain. For most, the fever passes within a week. The joint pain is the problem. In a meaningful minority of people it lasts for months, and sometimes for years. It can be genuinely disabling, and there is no specific treatment that reliably shortens it. The mosquito that carries chikungunya is the same type that carries dengue and Zika. It breeds in small amounts of standing water around houses: buckets, plant pot saucers, blocked gutters, discarded tyres. That is why outbreaks concentrate in cities rather than jungles, and why Managua is the focus here.
What the evidence actually says
Two things are worth handling carefully. The first is the case numbers. The CDC's figure and the figures in local reporting do not match. Official surveillance in any country can lag, and reporting systems vary in how completely they capture cases. Rather than pick one number, the honest position is that an outbreak is under way, it is growing, and the exact size is uncertain. The second is vaccination, where UK travellers need country-specific information rather than American advice. Two chikungunya vaccines are used in the UK. Vimkunya is a non-live vaccine. Ixchiq is a live attenuated vaccine. Ixchiq has been restricted following reports of serious side effects in older people. From 16 July 2025 the UK's Joint Committee on Vaccination and Immunisation advised against its use in adults aged 60 and over, and said it should not be given to anyone with a history of thymus disorder or thymus removal. In February 2026 the MHRA introduced further restrictions, limiting Ixchiq to adults aged 18 to 59 and contraindicating it in people aged 60 and over and in those with certain other health conditions. There is currently no evidence of a similar safety signal with Vimkunya in older adults. This is exactly why a travel clinic conversation matters. Which vaccine is appropriate, or whether one is appropriate at all, depends on your age, your health and where you are going. It is not a decision to make from a website. Protection also takes time to build. The general advice is to be vaccinated ideally two to four weeks before you travel.
Practical advice
If Nicaragua or the wider region is on your itinerary, here is what to do. Book a travel health appointment six to eight weeks before you go, with your GP practice, a travel clinic or a pharmacy that offers travel services. Ask specifically about chikungunya as well as routine vaccinations. Be honest about your age and health conditions in that conversation. The restrictions on Ixchiq exist for good reason, and the alternatives depend on your circumstances. Whatever you decide about vaccination, take bite prevention seriously. No chikungunya vaccine removes the need for it, and it also protects you from dengue and Zika, for which the options are more limited. Use an insect repellent containing DEET at a suitable strength, and reapply as directed. Wear loose long sleeves and long trousers where you can. Sleep in air-conditioned or screened rooms, or under a net. Remember that the mosquitoes involved bite during the day as well as at dawn and dusk, so daytime protection matters. If you are pregnant, discuss the trip with your midwife or doctor before booking. CDC advises reconsidering travel to affected areas, particularly late in pregnancy. If you develop a sudden fever with severe joint pain during your trip or after you get home, see a doctor and tell them exactly where you have been and when. Do not assume it is flu. And take out travel insurance that covers medical treatment abroad. Joint pain that lingers for months is also worth mentioning to your GP once home.
What to know
The CDC updated its Level 2 travel health notice for chikungunya in Nicaragua on 3 September 2026, advising enhanced precautions. Most cases are in Managua. The CDC notes more than 400 cases since May 2026, while local reporting suggests the true figure is higher. It is Nicaragua's first outbreak since 2021. Chikungunya is rarely fatal, but the joint pain it causes can persist for months or years in some people, and there is no specific cure. Two chikungunya vaccines are used in the UK. Ixchiq is now restricted to adults aged 18 to 59 following MHRA action in February 2026 and JCVI advice from July 2025. Vimkunya is a non-live alternative with no current safety signal in older adults. Vaccination is ideally given two to four weeks before travel, so book early. Bite avoidance matters regardless of vaccination, and protects against dengue and Zika too. Pregnant travellers, especially close to delivery, should discuss the trip with a healthcare professional before booking. Sources: US Centers for Disease Control and Prevention, "Chikungunya in Nicaragua - Level 2 - Practice Enhanced Precautions", updated 3 September 2026, https://wwwnc.cdc.gov/travel/notices/level2/chikungunya-nicaragua | NaTHNaC / TravelHealthPro, "Chikungunya vaccination information", https://travelhealthpro.org.uk/news/843/chikungunya-vaccination-information | NaTHNaC / TravelHealthPro, "Chikungunya" factsheet, https://travelhealthpro.org.uk/factsheets/chikungunya This article is for general information and does not replace advice from a doctor, pharmacist, travel health clinic or other qualified healthcare professional. Vaccine suitability depends on your age, health and destination, so seek personal advice before travelling.
Related articles
Dengue alert updated: twelve countries with unusually high cases, plus Cuba
The US Centers for Disease Control and Prevention updated its global dengue travel health notice on 3 September 2026. The notice sits at Level 1, meaning trave…
The DRC Ebola outbreak keeps growing: what UK travellers need to know
The Ebola outbreak in the Democratic Republic of the Congo is now the largest ever recorded in that country, and it is still growing. In an update published on…
September is peak season for typhoid in returning travellers
The UK Health Security Agency, known as UKHSA, publishes figures on infections picked up abroad by people returning to England. Its most recent data, published…